Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer

被引：1
作者：
Havard, Robert [1 ]
Henry, N. Lynn [1 ]
机构：
[1] Univ Utah, Dept Internal Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 28期
关键词：
21 gene recurrence score; 70 gene signature; breast cancer; chemotherapy; multiparameter genomic assays; prediction; prognosis; ADJUVANT SYSTEMIC THERAPY; AMERICAN SOCIETY; GENE-EXPRESSION; GUIDE DECISIONS; WOMEN; VALIDATION; SIGNATURE; BIOMARKERS; ASSAY;
D O I：
10.2217/fon-2017-0452
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2507 / 2510
页数：4
相关论文
共 50 条
  • [21] Decision-making impairments in breast cancer patients treated with tamoxifen
    Chen, Xingui
    Li, Jingjing
    Chen, Juluo
    Li, Dandan
    Ye, Rong
    Zhang, Jingjie
    Zhu, Chunyan
    Tian, Yanghua
    Wang, Kai
    HORMONES AND BEHAVIOR, 2014, 66 (02) : 449 - 456
  • [22] Unsettling the treatment imperative? Chemotherapy decision-making in the wake of genomic techniques
    Ross, Emily
    Kerr, Anne
    Swallow, Julia
    Chekar, Choon Key
    Cunningham-Burley, Sarah
    SOCIOLOGY OF HEALTH & ILLNESS, 2023, 45 (05) : 1063 - 1081
  • [23] A Decision-Making Supporting Prediction Method for Breast Cancer Neoadjuvant Chemotherapy
    Song, Dong
    Man, Xiaxia
    Jin, Meng
    Li, Qian
    Wang, Han
    Du, Ye
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [24] Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer
    Sanft, Tara
    Aktas, Bilge
    Schroeder, Brock
    Bossuyt, Veerle
    DiGiovanna, Michael
    Abu-Khalaf, Maysa
    Chung, Gina
    Silber, Andrea
    Hofstatter, Erin
    Mougalian, Sarah
    Epstein, Lianne
    Hatzis, Christos
    Schnabel, Cathy
    Pusztai, Lajos
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 154 (03) : 533 - 541
  • [25] Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective
    Peters, A. L.
    Hall, P. S.
    Jordan, L. B.
    Soh, F. Y.
    Hannington, L.
    Makaranka, S.
    Urquhart, G.
    Vallet, M.
    Cartwright, D.
    Marashi, H.
    Elsberger, B.
    BREAST, 2024, 75
  • [26] Integrating PANoptosis insights to enhance breast cancer prognosis and therapeutic decision-making
    Wang, Shu
    Li, Zhuolin
    Hou, Jing
    Li, Xukui
    Ni, Qing
    Wang, Tao
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [27] Impact of MammaPrint on Clinical Decision-Making in South African Patients with Early-Stage Breast Cancer
    Pohl, Heinrich
    Kotze, Maritha J.
    Grant, Kathleen A.
    van der Merwe, Lize
    Pienaar, Fredrieka M.
    Apffelstaedt, Justus P.
    Myburgh, Ettienne J.
    BREAST JOURNAL, 2016, 22 (04) : 442 - 446
  • [28] Genomic based personalized chemotherapy analysis to support decision systems for breast cancer
    Saribudak, Aydin
    Gundry, Stephen
    Zou, Jianmin
    Uyar, M. Umit
    2015 IEEE INTERNATIONAL SYMPOSIUM ON MEDICAL MEASUREMENTS AND APPLICATIONS (MEMEA) PROCEEDINGS, 2015, : 495 - 500
  • [29] Promoting emancipated decision-making for surgical treatment of early stage breast cancer among Jordanian women
    Obeidat, Rana F.
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2015, 2 (04) : 257 - 263
  • [30] Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
    Kurian, Allison W.
    Li, Yun
    Hamilton, Ann S.
    Ward, Kevin C.
    Hawley, Sarah T.
    Morrow, Monica
    McLeod, M. Chandler
    Jagsi, Reshma
    Katz, Steven J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (20) : 2232 - +
12345